The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study

The interactions between aromatase inhibitors (AI) in breast cancer (BC) and gut microbiota (GM) have not been completely established yet. The aim of the study is to evaluate the bio-diversity of GM and the relationship between GM, inflammation and tumor-infiltrating lymphocytes (TILs) in postmenopa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Angioletta Lasagna, Mara De Amici, Chiara Rossi, Valentina Zuccaro, Marta Corbella, Greta Petazzoni, Francesco Comandatore, Lucia Sacchi, Giorgia Testa, Elisa Ferraris, Gianpiero Rizzo, Richard Tancredi, Alessandra Ferrari, Marco Lucioni, Paolo Sacchi, Raffaele Bruno, Paolo Pedrazzoli
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-11-01
Edice:	Pathogens
Témata:	estrobolome microbiome TILs breast cancer IL17 aromatase inhibitors
On-line přístup:	https://www.mdpi.com/2076-0817/11/12/1421
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!